Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Crandall, Carolyn J ^a   Tseng, Chi Hong ^a   Karlamangla, Arun S ^a   Finkelstein, Joel S ^b   Randolph, John F ^c   Thurston, Rebecca C ^e   Huang, Mei Hua ^a   Zheng, Huiyong ^d   Greendale, Gail A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; LUMBAR SPINE; MENOPAUSE AND CLIMACTERIUM; MENSTRUAL CYCLE; OBSERVATIONAL STUDY; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRETRANSMENOPAUSAL; PRIORITY JOURNAL; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRANSMENOPAUSAL PHASE;

EID: 84876213336     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3651     Document Type: Article

References (58)

1. World Health Organization Scientific Group on Research on the Menopause in the 1990s. 1996 Research on the menopause in the 1990s: report of a WHO Scientific Group. Geneva: World Health Organization.
2. Seifert-Klauss V, Link T, Heumann C, et al. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas. 2006; 55:317-324.
3. Pouilles JM, Tremollieres F, Ribot C. The effects of menopause on longitudinal bone loss from the spine. Calcif Tissue Int. 1993;52: 340-343.
4. Komukai S, Ohta H, Makita K, et al. One-year spinal bone change in pre- and perimenopausal Japanese women. A prospective observational study. Horm Res. 2003;59:79-84.
5. Ahlborg HG, Johnell O, Nilsson BE, Jeppsson S, Rannevik G, Karlsson MK. Bone loss in relation to menopause: a prospective study during 16 years. Bone. 2001;28:327-331.
6. Chapurlat RD, Garnero P, Sornay-Rendu E, Arlot ME, Claustrat B, Delmas PD. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int. 2000;11:493-498.
7. Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 1996;81:3366-3371.
8. Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, Offord KP. Rates of bone lossinthe appendicular and axialskeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986;77:1487-1491.
9. Sowers MR, Zheng H, Jannausch ML, et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 2010;95:2155-2162.
10. Riggs BL, Khosla S, Melton LJ 3rd. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-773.
11. Khosla S, Melton LJ 3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. 2011;26:441-451.
12. Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23:205-214.
13. Guthrie JR, Ebeling PR, Hopper JL, et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int. 1998;8:282-290.
14. Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest. 1987;80:1261-1269.
15. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008;93:861-868.
16. Sowers M, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res. 1998;13:1134-1140.
17. Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2011;96:746-754.
18. Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multi-ethic cohort: results from the study of women's health across the nation (SWAN). J Bone Miner Res. 2011;27:111-118.
19. Cheung E, Tsang S, Bow C, et al. Bone loss during menopausal transition among southern Chinese women. Maturitas. 2011;69: 50-56.
20. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. J Bone Miner Res. 2000; 15:1835-1841.
21. Guthrie JR, Lehert P, Dennerstein L, Burger HG, Ebeling PR, Wark JD. The relative effect of endogenous estradiol and and rogens on menopausal bone loss: a longitudinal study. Osteoporos Int. 2004; 15:881-886.
22. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21:103-113.
23. Sowers MR, Jannausch M, McConnell D, et al. Hormonepredictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab. 2006;91:1261-1267.
24. Seifert-Klauss V, Fillenberg S, Schneider H, Luppa P, Mueller D, Kiechle M. Bone loss in premenopausal, perimenopausal and post-menopausal women: results of a prospective observational study over 9 years. Climacteric. 2012;15:433-440.
25. Rariy CM, Ratcliffe SJ, Weinstein R, et al. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the Cardiovascular Health Study. J Clin Endocrinol Metab. 2011;96:989-996.
26. Johnston CC Jr, Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab. 1985;61:905-911.
27. Lambrinoudaki I, Christodoulakos G, Aravantinos L, et al. Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women. J Bone Miner Metab. 2006;24:65-71.
28. Zofkova I, Bahbouh R, Hill M. The pathophysiological implications of circulating and rogens on bone mineral density in a normal female population. Steroids. 2000;65:857-861.
29. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69:533-539.
30. van Geel TA, Geusens PP, Winkens B, Sels JP, Dinant GJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol. 2009;160:681-687.
31. Bagur A, Oliveri B, Mautalen C, et al. Low levels of endogenous estradiol protect bone mineral density in young postmenopausal women. Climacteric. 2004;7:181-188.
32. Tok EC, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S. The effec to fcirculating and rogensonbone mineral density in postmenopausal women. Maturitas. 2004;48:235-242.
33. Murphy S, Khaw KT, Sneyd MJ, Compston JE. Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgrad Med J. 1992;68:908-913.
34. Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf). 2002;56:703-711.
35. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15:1526-1536.
36. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1998;339:733-738.
37. Lee JS, LaCroix AZ, Wu L, et al. Associations of serum sex hormonebinding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women. J Clin Endocrinol Metab. 2008;93: 1796-1803.
38. Bjornerem A, Ahmed LA, Joakimsen RM, et al. A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study. Eur J Endocrinol. 2007;157:119-125.
39. Goderie-Plomp HW, van der Klift M, de Ronde W, Hofman A, de Jong FH, Pols HA. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. J Clin Endocrinol Metab. 2004;89:3261-3269.
40. Sowers M, Crawford S, Sternfeld B, Morganstein D, Gold E. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Menopause: Biology and Pathobiology. San Diego: Academic Press; 2000:175-188.
41. Hans D, Duboeuf F, Schott AM, et al. Effects of a new positioner on the precision of hip bone mineral density measurements. J Bone Miner Res. 1997;12:1289-1294.
42. England BG, Parsons GH, Possley RM, McConnell DS, Midgley AR. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem. 2002;48:1584-1586.
43. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67:598-607.
44. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
45. Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol. 2001;154:1089-1099.
46. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
47. Gao J, Tiwari-Pandey R, Samadfam R, et al. Altered ovarian function affects skeletal homeostasis independent of the action of folliclestimulating hormone. Endocrinology. 2007;148:2613-2621.
48. Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S. Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab. 2010;95:5063-5068.
49. Drake MT, Khosla S. Role of sex steroids in the pathogenesis of osteoporosis. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington DC: American Society for Bone and Mineral Research; 2008.
50. Seeman E, Delmas PD. Bone quality - the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250-2261.
51. Venken K, Boonen S, Bouillon R, Vanderschueren D. Gonadal steroids. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington DC: American Society for Bone and Mineral Research; 2008.
52. Hoppe E, Bouvard B, Royer M, Audran M, Legrand E. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine. 2010;77: 306-312.
53. Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA. Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol. 2010;316:79-85.
54. Hui SL, Perkins AJ, Zhou L, et al. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sexhormone levels. J Clin Endocrinol Metab 2002;87:1539-1543.
55. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86:225-230.
56. Nicks KM, Fowler TW, Gaddy D. Reproductive hormones and bone. Curr Osteoporos Rep. 2010;8:60-67.
57. Stanczyk FZ, Jurow J, Hsing AW. Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2010;19:903-906.
58. Yang DT, Owen WE, Ramsay CS, Xie H, Roberts WL. Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol. 2004;122:332-337.